Using the in vivo colitis model and in vitro induction and microenvironment co-culture models of primary effector T cells from mouse and human, we find that EGCG displays an enhanced effects on expression levels of colonic GPR43 and its activity. The gene discussed is FFAR2; the disease is colitis.